This Advisory Notice supersedes Market Regulation Advisory Notice RA 1404-5 from August 8, 2014. It is being issued to notify the marketplace that, pending all relevant CFTC regulatory review periods, the following two (2) NYMEX products will be eligible for the Agency Cross functionality pursuant to Rule 539 and corresponding guidance.
Click HERE for the full advisory
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.